← Who reports today · Financials
How CME Group (CME) makes money: Q3 2026 revenue breakdown
Net Income
$1,037M
up 14.2% y/y
Total Revenues
$1,737M
up 13.0% y/y
Operating Income
$1,141M
up 17.4% y/y
Next report
~ Feb 3
not announced yet
The quarter in brief
Record third-quarter revenue rose 13.0% y/y to $1,737.3M; clearing and transaction fees grew to $1,378.1M and market data to $243.1M; operating income rose 17.4% to $1,141.4M and net income 14.2% to $1,036.9M ($2.89 per diluted share vs $2.49).
Key growth driver: Clearing and transaction fees — the fastest-growing revenue line: $1,378, +12% y/y. · by the Q3 2026 report
How does CME Group make money?
CME Group brought in $1.74 billion of revenue in Q3 2026, up 13.0% year over year. The largest source was Clearing and transaction fees: $1.38 billion, or 79% of the total, followed by Market data and information services ($243M, 14%); other lines add the remaining 7%. Net income for the quarter was $1.04 billion, up 14.2% year over year.
Revenue by source, Q3 2026
- Clearing and transaction fees$1.38B · 79% · +12.2%
- Market data and information services$243M · 14% · +20.0%
- Other$116M · 7% · +8.3%
Shares of $1.74B total revenue; changes are year over year, as reported. ≈ marks lines derived from disclosed totals. The same flows are drawn in the Sankey chart below.
All figures in $M.
| Line item | Amount and change |
|---|---|
| Clearing and transaction fees | $1,378 · +12.2% |
| Market data and information services | $243 · +20.0% |
| Other | $116 · +8.3% |
| Total Revenues | $1,737 · +13.0% |
| Compensation and benefits | $234 · −1.4% |
| Technology | $80.9 · +13.3% |
| Professional fees and outside services | $31.1 · −15.3% |
| Amortization of purchased intangibles | $56 · −0.4% |
| Depreciation and amortization | $27.4 · +3.8% |
| Licensing and other fee agreements | $104 · +27.7% |
| Other | $62 · +12.5% |
| Operating Income | $1,141 · +17.4% · 65.7% margin |
| Investment income less other non-operating expense (calculated) | $154 · +1.3% |
| Interest and other borrowing costs | $43.5 · −1.1% |
| Equity in net earnings of unconsolidated subsidiaries | $103 · +6.7% |
| Income before Income Taxes | $1,355 · +15.1% |
| Income tax provision | $318 · +18.2% · 23.5% effective rate |
| Net Income | $1,037 · +14.2% · $2.89/sh · 59.7% margin |
Verdict: record third-quarter revenue rose 13.0% y/y to $1,737.3M; clearing and transaction fees grew to $1,378.1M and market data to $243.1M; operating income rose 17.4% to $1,141.4M and net income 14.2% to $1,036.9M ($2.89 per diluted share vs $2.49).
Adjusted diluted EPS (non-GAAP) $3.02; average daily volume a third-quarter record 29.4 million contracts; nearly $1 billion returned to shareholders in the quarter ($465 million of dividends and $524 million of buybacks).
Source and notation
Source: CME Group earnings release, 8-K EX-99 of 10/21/2026 (SEC EDGAR). Financial-services layout: net revenues as reported (for brokers, after interest expense); expenses by line of the income statement lead to pre-tax income. The income statement lines were taken from the release by hand; the program found every figure in the release text and checked the accounting identities and the chart balance; SEC XBRL for this quarter is not published yet, so the XBRL check is pending.
Open as an image: CME Group (CME), Q3 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “CME Group (CME) Q3 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/cme. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/cme"><img src="https://whoreportstoday.com/t/cme/img/cme-group-earnings-sankey.png" alt="CME Group (CME) Q3 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/cme">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/cme/img/cme-group-earnings-sankey.png
<a href="https://whoreportstoday.com/t/cme">CME Group (CME) Q3 2026 earnings chart (Who Reports Today)</a>
The image link always shows the latest report’s chart and will update with the next quarter. To keep this exact chart in your article, save the PNG and upload it yourself — the license allows that. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Investment income was $1,418.1M against $1,264.0M of other non-operating expense (largely interest paid on clearing members' cash), netting to a small positive contribution shown as one line.
- Market data revenue was a record $243 million, an increase of 20%; the total average rate per contract was $0.679.
- Licensing and other fee agreements rose to $104.2M from $81.6M with higher volumes.
- The effective tax rate was 23.5% vs 22.9% a year earlier.
What distorts the picture in this report and what to watch beyond the headlines.
CME Group Inc., headquartered in Chicago, Illinois, operates exchanges and provides clearing services for trading in financial derivatives such as futures contracts, options, and swaps. · Text: Wikipedia, CC BY-SA 4.0, abridged
Its exchanges include the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company operates the Globex Trading System, an electronic trading platform that allows customers in approximately 150 countries to trade futures and options contracts. The company also operates two platforms for spot market trading: BrokerTec, which facilitates dealer-to-dealer trading in fixed-income products, and EBS, which provides spot trading in foreign exchange markets. CME Clearing serves as a counterparty to every transaction cleared by the company.
Company reports
Company guidance
The company does not publish guidance in its earnings release.
Same quarter a year ago (ended December 31, 2025): revenue $1.65B, EPS (GAAP) $3.24
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
Guidance comes from the company's earnings release (Form 8-K filed Oct 21, 2026); every figure is checked against the release text.
CME earnings history: past report dates
| Oct 21, 2026 Wed | 7:13 ambefore market open | Sep 30, 2026 | $1.7B+13% y/y | $2.89+16% y/y |
| Jul 22, 2026 Wed | 7:15 ambefore market open | Jun 30, 2026 | $1.7B+1% y/y | $2.88+2% y/y |
| Apr 22, 2026 Wed | 7:13 ambefore market open | Mar 31, 2026 | $1.9B+14% y/y | $3.18+21% y/y |
| Feb 4, 2026 Wed | 7:06 ambefore market open | Dec 31, 2025 | ≈$1.6B+8% y/y | ≈$3.24+35% y/y |
| Oct 22, 2025 Wed | 7:05 ambefore market open | Sep 30, 2025 | $1.5B−3% y/y | $2.49−0% y/y |
| Jul 23, 2025 Wed | 7:08 ambefore market open | Jun 30, 2025 | $1.7B+10% y/y | $2.81+16% y/y |
| Apr 23, 2025 Wed | 7:07 ambefore market open | Mar 31, 2025 | $1.6B+10% y/y | $2.62+11% y/y |
| Feb 12, 2025 Wed | 7:05 ambefore market open | Dec 31, 2024 | ≈$1.5B+6% y/y | ≈$2.40+8% y/y |
| Oct 23, 2024 Wed | 7:06 ambefore market open | Sep 30, 2024 | $1.6B+18% y/y | $2.50+21% y/y |
| Jul 24, 2024 Wed | 7:10 ambefore market open | Jun 30, 2024 | $1.5B+13% y/y | $2.42+13% y/y |
| Apr 24, 2024 Wed | 7:05 ambefore market open | Mar 31, 2024 | $1.5B+3% y/y | $2.35−3% y/y |
| Feb 14, 2024 Wed | 7:08 ambefore market open | Dec 31, 2023 | ≈$1.4B+19% y/y | ≈$2.23+27% y/y |
| Oct 25, 2023 Wed | 7:05 ambefore market open | Sep 30, 2023 | $1.3B+9% y/y | $2.06+10% y/y |
| Jul 26, 2023 Wed | 7:04 ambefore market open | Jun 30, 2023 | $1.4B+10% y/y | $2.14+18% y/y |
| Apr 26, 2023 Wed | 7:06 ambefore market open | Mar 31, 2023 | $1.4B+7% y/y | $2.43+25% y/y |
| Feb 8, 2023 Wed | 7:15 ambefore market open | Dec 31, 2022 | ≈$1.2B+5% y/y | ≈$1.76+4% y/y |
Show all 16 reports since 2023Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
CME Group: 15-year financials
| 2025 | 6,521 | 4,230 | 4,072 | 4,194 | 3,933 |
| 2024 | 6,130 | 3,932 | 3,526 | 3,597 | 3,584 |
| 2023 | 5,579 | 3,436 | 3,226 | 3,377 | 3,236 |
| 2022 | 5,019 | 3,016 | 2,691 | 2,966 | 2,634 |
| 2021 | 4,690 | 2,645 | 2,637 | 2,275 | 2,189 |
| 2020 | 4,884 | 2,637 | 2,106 | 2,518 | 2,110 |
| 2019 | 4,868 | 2,588 | 2,117 | 2,427 | 1,696 |
| 2018 | 4,309 | 2,608 | 1,962 | 2,324 | 2,150 |
| 2017 | 3,645 | 2,311 | 4,063 | 1,669 | 1,994 |
| 2016 | 3,595 | 2,201 | 1,534 | 1,640 | 1,787 |
| 2015 | 3,327 | 1,989 | 1,247 | 1,418 | 1,343 |
| 2014 | 3,113 | 1,768 | 1,127 | 1,151 | 1,497 |
| 2013 | 2,936 | 1,637 | 977 | 1,155 | 599 |
| 2012 | 2,915 | 1,692 | 896 | 1,078 | 1,224 |
| 2011 | 3,281 | 2,021 | 1,812 | 1,174 | 373 |
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
CME Group: 15-year balance sheet
| Year | Assets | Equity | Cash | Current assets | Current liabilities |
|---|---|---|---|---|---|
| 2025 | 198,424 | 28,728 | 4,417 | 165,359 | 160,297 |
| 2024 | 137,447 | 26,487 | 2,892 | 103,034 | 102,314 |
| 2023 | 129,706 | 26,738 | 2,912 | 94,890 | 93,417 |
| 2022 | 174,176 | 26,879 | 2,720 | 139,078 | 137,688 |
| 2021 | 196,780 | 27,399 | 2,835 | 161,762 | 160,398 |
| 2020 | 124,660 | 26,352 | 1,633 | 89,284 | 88,198 |
| 2019 | 75,215 | 26,159 | 1,551 | 39,568 | 38,523 |
| 2018 | 77,476 | 25,965 | 1,375 | 41,887 | 41,273 |
| 2017 | 75,791 | 22,412 | 1,904 | 46,907 | 45,673 |
| 2016 | 69,369 | 20,341 | 1,869 | 40,032 | 38,946 |
| 2015 | 67,359 | 20,552 | 1,693 | 37,905 | 36,825 |
| 2014 | 72,242 | 20,924 | 1,366 | 42,545 | 41,531 |
| 2013 | 54,278 | 21,155 | 2,470 | 24,406 | 23,311 |
| 2012 | 38,863 | 21,419 | 1,605 | 8,718 | 7,617 |
| 2011 | 40,759 | 21,552 | 1,042 | 10,946 | 9,615 |
$ millions, at fiscal year-end*.
* Sources
How we calculate
Annual balance sheet figures. “—” means no data; zero appears only when a numeric zero is present. Metrics with fewer than two values are omitted. Annual amounts use the financial screener data, in the reporting currency. Equity is attributable to shareholders where available, otherwise total equity including noncontrolling interests. Debt and cash follow the stored figures: they may include leases and restricted cash. Snapshot updated: .
Cash flow
9 months ended 2026-09-30 · $M
| Line | This period | Year ago | Δ |
|---|---|---|---|
| Operating cash flowcash the business generated | 3,293 | 3,143 | +150 |
| · incl. D&A (non-cash add-back)depreciation & amortization | 82.8 | 81 | |
| · incl. stock-based comp (non-cash)share-based compensation | 70.7 | 65.9 | |
| Capexpurchases of property & equipment | −61.2 | −51 | −10.2 |
| Free cash flow ≈operating cash flow − capex | 3,232 | 3,092 | +140 |
| Investing activities, netcapex, acquisitions, securities | −73 | −53.1 | −19.9 |
| Financing activities, netdebt, buybacks, dividends | −9,918 | 46,610 | −56,528 |
| · incl. dividends paid | −3,631 | −3,478 | −153 |
| Net change in cash | −6,698 | 49,700 | −56,398 |
How to read the table
Cash flow is cumulative from the start of the fiscal year, rather than a single quarter. Lines marked ≈ are derived. Green Δ means more cash in (or less out) than a year ago. ≈ in Δ means a difference that rounds to zero at the displayed precision.
Shareholders’ equity at Sep 30, 2026: $26.6B (14% of total assets). Compare with other S&P 500 companies →
Corporate governance
1.5/2mostly good
- Jun 20268-K: on Jun 9, 2026 proposals to eliminate the right of Class B-1 to elect three directors and of Class B-2 to elect two failed (27.8% of B-1 shares voted for, short of the required majority); B-3 lacked a quorum. sec.gov ↗
- Mar 20262026 proxy: the board proposed eliminating Class B director election rights to remove what investors view as a "dual-class" structure. sec.gov ↗
2 more facts and scoring
How the company treats minority shareholders: 2 — well, 0 — systematically poorly.
- Feb 202610-K FY2025: 358.6M Class A shares vs. 625/813/1,287 Class B-1/B-2/B-3 shares; annual variable dividend of $6.15 declared on Feb 12, 2026. sec.gov ↗
- Feb 2026Diluted shares 358.5M (2020) → 360.3M (2025), +0.5%. data.sec.gov ↗
Scoring: 2.0 −0.5 (criterion 7: ~3,100 Class B shares held by exchange members elect 6 of ~20 directors, no sunset; no majority; the attempt to eliminate the right failed in Jun 2026) = 1.5; dilution +0.5% over 5 years, regular + variable dividend per policy
- Share classes
- Class B-1/B-2/B-3 (625+813+1,287 shares, tied to trading rights) separately elect 3+2+1 directors; the board's proposal to eliminate this right failed on Jun 9, 2026 (Class B majority not reached) → −0.5.
- Dilution
- Diluted shares 358.5M (2020) → 360.3M (2025), +0.5%; SBC 1.5%; 2021 Series G preferred (Google) — at market, convertible 1:1.
- Disclosure
- Full reporting.
- Dividends
- Regular quarterly dividend + annual variable dividend based on the year's results (for 2025 — $6.15, declared Feb 12, 2026); the 2025 dip in XBRL reflects a shift in the declaration date.
- Lawsuits & regulators
- 10-K FY2025 shows no shareholder suits or SEC cases; CFTC matters are industry-related.
- Related parties
- BlackRock (>5%) receives $0.55M for clearing consulting — market terms.
How the score works · checked as of Oct 2026
Included in screener lists: S&P 500 companies that paid dividends 10 years without a gap · Piotroski F-score: S&P 500 companies scoring 8 or 9
CME Group (CME) earnings: FAQ
How does CME Group make money?
CME Group brought in $1.74 billion of revenue in Q3 2026, up 13.0% year over year. The largest source was Clearing and transaction fees: $1.38 billion, or 79% of the total, followed by Market data and information services ($243M, 14%); other lines add the remaining 7%. Net income for the quarter was $1.04 billion, up 14.2% year over year.
When is CME's next earnings date?
We have not yet seen an announcement of the date from CME Group (CME). Based on last year's report on Feb 4, 2026, the next report is expected around Feb 3, 2027.
What time does CME report earnings?
CME Group usually reports before market open: its latest results release was filed with the SEC at 7:13 am ET on Oct 21, 2026.
When did CME last report earnings?
CME Group reported Q3 2026 results on Oct 21, 2026.
Where can I find CME Group's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to CME's filings; this page breaks the latest report down in a Sankey chart.
What was CME's net income in Q3 2026?
CME Group reported net income of $1,037M for Q3 2026 (+14.2% year over year), under US GAAP.
Does CME Group pay dividends?
Yes. In 2025, CME Group paid $3,933M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.
How has CME Group's revenue changed since 2011?
Per its 10-K filings, revenue grew 2x: $3,281M in 2011 and $6,521M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
Get it every Monday: who reports this week
Once a week: companies that announced report dates for the week ahead (US and Canada), fresh report breakdowns with charts. Free, no account needed.
More reports: COF · Q3 2026 · COIN · Q3 2026 · CPAY · Q3 2026 · EG · Q3 2026 · ERIE · Q3 2026 · FDS · Q4 FY2026 · FIS · Q3 2026 · FISV · Q3 2026 · FITB · Q3 2026 · GL · Q3 2026 · all reports